RxDoctor Payments Data

Linda Arnold Walker, MD

Family Medicine · Gray, GANPI 1194710293

Payments from drug & device makers

$10,410in general payments, 2019–2025

Across 618 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Pfizer$1K
  • Novo Nordisk$874
  • Amgen$629
  • GSK$603
  • plus $4K from 50 others

What the payments were for

  • Food & beverage$10,410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,410 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$193,322
Medicare patients
378
Services billed
20,646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol241$184,148
OzempicSemaglutide135$148,670
JardianceEmpagliflozin96$105,686
EliquisApixaban112$101,080
ArexvyRsvpref3 Antigen/As01e/Pf324$100,710
Enbrel SureclickEtanercept13$95,388
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$75,066
XareltoRivaroxaban73$64,551
JanuviaSitagliptin Phosphate43$47,681
MounjaroTirzepatide33$40,230
MyrbetriqMirabegron67$38,883
TradjentaLinagliptin43$38,216
TrulicityDulaglutide32$35,334
JanumetSitagliptin Phos/Metformin Hcl46$33,585
LinzessLinaclotide38$32,106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$1,569$235,831341 claims
GSKArexvy, Trelegy Ellipta, Shingrix, Breo Ellipta, Anoro Ellipta$603$227,341584 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$336$163,857182 claims
Novo NordiskOzempic, Rybelsus$874$161,366147 claims
PfizerEliquis, Premarin$1,167$109,088133 claims
MerckJanuvia, Janumet, Belsomra$297$89,555102 claims
Lilly USA, LLCMounjaro, Trulicity$280$75,56465 claims
Johnson & JohnsonXarelto$148$64,55173 claims
AbbVieLinzess, Vraylar$1,357$49,18550 claims
Astellas Pharma US IncMyrbetriq$101$38,88367 claims
Otsuka America Pharmaceutical, Inc.Rexulti$286$15,98711 claims
NovartisEntresto$16$10,57011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Gray

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →